| Epidemiologic and molecular prognostic review of glioblastoma JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom, DD Lightner, ... Cancer epidemiology, biomarkers & prevention 23 (10), 1985-1996, 2014 | 1903 | 2014 |
| Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ... Neuro-oncology 22 (8), 1073-1113, 2020 | 970 | 2020 |
| Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ... Nature medicine 25 (3), 462-469, 2019 | 776 | 2019 |
| CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ... Cancer research 76 (19), 5671-5682, 2016 | 602 | 2016 |
| An overview of meningiomas RA Buerki, CM Horbinski, T Kruser, PM Horowitz, CD James, RV Lukas Future oncology 14 (21), 2161-2177, 2018 | 575 | 2018 |
| Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death J Zhu, C Horbinski, F Guo, S Watkins, Y Uchiyama, CT Chu The American journal of pathology 170 (1), 75-86, 2007 | 541 | 2007 |
| DMT1: a mammalian transporter for multiple metals MD Garrick, KG Dolan, C Horbinski, AJ Ghio, D Higgins, M Porubcin, ... Biometals 16, 41-54, 2003 | 452 | 2003 |
| Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer ML Zhu, CM Horbinski, M Garzotto, DZ Qian, TM Beer, N Kyprianou Cancer research 70 (20), 7992-8002, 2010 | 425 | 2010 |
| Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas A Piunti, R Hashizume, MA Morgan, ET Bartom, CM Horbinski, ... Nature medicine 23 (4), 493-500, 2017 | 406 | 2017 |
| Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology LB Nabors, J Portnow, M Ahluwalia, J Baehring, H Brem, S Brem, ... Journal of the National Comprehensive Cancer Network 18 (11), 1537-1570, 2020 | 404 | 2020 |
| Mitochondrial control by DRP1 in brain tumor initiating cells Q Xie, Q Wu, CM Horbinski, WA Flavahan, K Yang, W Zhou, ... Nature neuroscience 18 (4), 501-510, 2015 | 397 | 2015 |
| Preferential iron trafficking characterizes glioblastoma stem-like cells DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ... Cancer cell 28 (4), 441-455, 2015 | 326 | 2015 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 301 | 2022 |
| Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ... Clinical Cancer Research 22 (21), 5337-5348, 2016 | 296 | 2016 |
| Kinase signaling cascades in the mitochondrion: a matter of life or death C Horbinski, CT Chu Free Radical Biology and Medicine 38 (1), 2-11, 2005 | 280 | 2005 |
| Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression JS Hale, B Otvos, M Sinyuk, AG Alvarado, M Hitomi, K Stoltz, Q Wu, ... Stem cells 32 (7), 1746-1758, 2014 | 268 | 2014 |
| Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes F Nassiri, A Chakravarthy, S Feng, SY Shen, R Nejad, JA Zuccato, ... Nature medicine 26 (7), 1044-1047, 2020 | 245 | 2020 |
| Mutant IDH1 and seizures in patients with glioma H Chen, J Judkins, C Thomas, M Wu, L Khoury, CG Benjamin, D Pacione, ... Neurology 88 (19), 1805-1813, 2017 | 240 | 2017 |
| A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma P Kumthekar, CH Ko, T Paunesku, K Dixit, AM Sonabend, O Bloch, M Tate, ... Science translational medicine 13 (584), eabb3945, 2021 | 237 | 2021 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 236 | 2019 |
C. David JamesProfessor Emeritus, Feinberg School of Medicine, Northwestern Universityยืนยันอีเมลแล้วที่ northwestern.edu